Observational studyClinical research in cardiology : official journal of the German Cardiac Society2026
Left atrium strain in rheumatoid arthritis patients - a sub-study of the prospective Porto-RA cohort.
Observational study in Clinical research in cardiology : official journal of the German Cardiac Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRheumatoid arthritis (RA) increases heart failure (HF) risk. Left atrial strain (LAs) may allow early detection of cardiac disease but has been seldom studied in RA. This study evaluated associations between LAs, clinical, laboratory, and echocardiographic parameters, and outcomes in RA patients without known cardiac disease.
methodsIn this prospective observational study, RA patients underwent LAs analysis and were stratified into two groups by the median left atrium reservoir strain (LARs). The primary endpoint was a composite of myocardial infarction, stroke, atrial fibrillation, HF hospitalization, or cardiovascular death; secondary endpoints were its individual components and all-cause mortality. Median follow-up was 6.2 years.
resultsOf 364 patients enrolled, 260 underwent LAs analysis and comprised the final cohort (median LARs 37.4%). LARs ≤ median (n = 131, 50.4%) was associated with older age, shorter 6-min walk distance, higher troponin-T and NT-proBNP, higher E/e', and lower left-ventricular global longitudinal strain. Primary endpoint incidence was numerically higher in patients with LARs ≤ median, but did not differ significantly between groups (15.5 vs 10.3 events/1000 patient-years; HR 0.64 [0.26-1.57]; p = 0.33). A trend toward higher all-cause mortality was observed in the lower LARs group (12.5 vs 3.75 events/1000 patient-years; HR 0.29 [0.078-1.04]; p = 0.06), with no significant differences in other secondary endpoints.
conclusionIn RA patients, LARs ≤ 37.4% was associated with shorter walked distances, more pronounced cardiac structural, functional and biomarker alterations. While not significantly associated with adverse cardiovascular outcomes, the findings underscore the need for larger prospective studies to further explore this potential relationship.
Indexed as
Identifiers
41400670What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.